Advent Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-36,900
| Closed | -$2.35M | – | 242 |
|
|
2025
Q1 | $2.35M | Buy |
+36,900
| New | +$2.35M | 0.05% | 160 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 240 |
|
|
2024
Q3 | – | Sell |
-10,000
| Closed | -$1.58M | – | 228 |
|
|
2024
Q2 | $1.58M | Sell |
10,000
-10,000
| -50% | -$1.58M | 0.04% | 144 |
|
|
2024
Q1 | $2.59M | Buy |
20,000
+6,000
| +43% | +$777K | 0.07% | 128 |
|
|
2023
Q4 | $1.35M | Buy |
+14,000
| New | +$1.35M | 0.03% | 162 |
|
|
2023
Q2 | – | Sell |
-560
| Closed | -$77.2K | – | 231 |
|
|
2023
Q1 | $77.2K | Buy |
+560
| New | +$77.2K | ﹤0.01% | 188 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 219 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 223 |
|
|
2019
Q2 | – | Sell |
-2,000
| Closed | -$238K | – | 216 |
|
|
2019
Q1 | $238K | Buy |
+2,000
| New | +$238K | 0.01% | 180 |
|